The JAK2 V617F mutation is found rarely in aCML cases [23, 24], while it is frequent in Polycythaemia Vera (PV), Essential Thrombocythemia (ET) and Myelofibrosis (MF) [5]. This evidence concerns the gene JAK2 and atypical chronic myeloid leukemia, BCR-ABL1 negative.